Loading…
Ibuprofen does not prevent postbronchoscopy fever in children undergoing broncho‐alveolar lavage
Background Fiber‐optic bronchoscopy (FOB) of the lower airways is a routine examination performed for investigating varying respiratory complaints in children. A common side effect is a transient high fever on the day of the FOB. Such episodes are usually unrelated to an infectious process but may c...
Saved in:
Published in: | Pediatric pulmonology 2020-10, Vol.55 (10), p.2737-2741 |
---|---|
Main Authors: | , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c3572-f7833943adcc802fe732634f0d0d310fed4aebde6ccb7306dea00c7c3c0dbc8f3 |
---|---|
cites | cdi_FETCH-LOGICAL-c3572-f7833943adcc802fe732634f0d0d310fed4aebde6ccb7306dea00c7c3c0dbc8f3 |
container_end_page | 2741 |
container_issue | 10 |
container_start_page | 2737 |
container_title | Pediatric pulmonology |
container_volume | 55 |
creator | Joseph, Leon Goldberg, Shmuel Cohen, Shlomo Picard, Elie |
description | Background
Fiber‐optic bronchoscopy (FOB) of the lower airways is a routine examination performed for investigating varying respiratory complaints in children. A common side effect is a transient high fever on the day of the FOB. Such episodes are usually unrelated to an infectious process but may cause clinical uncertainty and parental anxiety. We have previously shown that a single dose of systemic dexamethasone significantly reduces the rate of fever postbronchoscopy (FPB).
Research Question
To prospectively analyze the effect of a prophylactic dose of ibuprofen upon the FPB.
Study Design and Methods
Children presenting for elective FOB and broncho‐alveolar lavage (BAL) were randomized, in a double‐blind fashion, to receive a single dose of ibuprofen syrup 10 mg/kg or placebo prior to the procedure. Parents were contacted the next day to record the presence or absence of fever.
Results
Sixty‐one children were included in the final analysis. Thirty‐one children were in the treatment group and 30 in the placebo group. FPB occurred in 40 children (65%). There was no difference in the rate of FPB between placebo (63%) and treatment (67%) groups (P = .717). Fifty (82%) children had a positive BAL culture. Among them, 38 had FPB (76%) compared with only 2 of 11 (18%) of those with negative culture (P = .00026, relative risk 4.18). About 80% of positive cultures grew Haemophilus influenza. There was no significant difference between the number of BALs with a positive culture between the treatment and placebo groups (87% vs 77%, P = .35).
Conclusion
FPB occurs in around twothirds of children when BAL is performed. Fever occurred significantly more frequently when BAL culture is positive. A single standard dose of the nonsteroidal anti‐inflammatory drug ibuprofen administered before a FOB does not prevent FPB. |
doi_str_mv | 10.1002/ppul.24992 |
format | article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2428415861</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2442594400</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3572-f7833943adcc802fe732634f0d0d310fed4aebde6ccb7306dea00c7c3c0dbc8f3</originalsourceid><addsrcrecordid>eNp90MtOGzEUBmCratWE0A0PgEbqBiENHF_mtkSoLUiRYFHWI499nEzk2IOdCcquj8Az9klqSMqCBasj2Z9_-fyEnFC4oADschhGe8FE07BPZEqhaXIQTfmZTOuqKPKyLvmEHMW4Akh3Df1KJpxVrGgKMSXdbTcOwRt0mfYYM-c32RBwiy5NHzdd8E4tfVR-2GUmnYesd5la9laH9GZ0GsPC926RHeTfP8_SbtFbGTIrt3KBx-SLkTbit8OckYefP35f3-Tzu1-311fzXPGiYrmpas4bwaVWqgZmsOKs5MKABs0pGNRCYqexVKqrOJQaJYCqFFegO1UbPiNn-9y0z-OIcdOu-6jQWunQj7FlgtWCFnVJE_3-jq78GFz6XVIiVSMEQFLne6WCjzGgaYfQr2XYtRTal-bbl-bb1-YTPj1Ejt0a9Rv9X3UCdA-eeou7D6La-_uH-T70HwQ4kdc</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2442594400</pqid></control><display><type>article</type><title>Ibuprofen does not prevent postbronchoscopy fever in children undergoing broncho‐alveolar lavage</title><source>Wiley</source><creator>Joseph, Leon ; Goldberg, Shmuel ; Cohen, Shlomo ; Picard, Elie</creator><creatorcontrib>Joseph, Leon ; Goldberg, Shmuel ; Cohen, Shlomo ; Picard, Elie</creatorcontrib><description>Background
Fiber‐optic bronchoscopy (FOB) of the lower airways is a routine examination performed for investigating varying respiratory complaints in children. A common side effect is a transient high fever on the day of the FOB. Such episodes are usually unrelated to an infectious process but may cause clinical uncertainty and parental anxiety. We have previously shown that a single dose of systemic dexamethasone significantly reduces the rate of fever postbronchoscopy (FPB).
Research Question
To prospectively analyze the effect of a prophylactic dose of ibuprofen upon the FPB.
Study Design and Methods
Children presenting for elective FOB and broncho‐alveolar lavage (BAL) were randomized, in a double‐blind fashion, to receive a single dose of ibuprofen syrup 10 mg/kg or placebo prior to the procedure. Parents were contacted the next day to record the presence or absence of fever.
Results
Sixty‐one children were included in the final analysis. Thirty‐one children were in the treatment group and 30 in the placebo group. FPB occurred in 40 children (65%). There was no difference in the rate of FPB between placebo (63%) and treatment (67%) groups (P = .717). Fifty (82%) children had a positive BAL culture. Among them, 38 had FPB (76%) compared with only 2 of 11 (18%) of those with negative culture (P = .00026, relative risk 4.18). About 80% of positive cultures grew Haemophilus influenza. There was no significant difference between the number of BALs with a positive culture between the treatment and placebo groups (87% vs 77%, P = .35).
Conclusion
FPB occurs in around twothirds of children when BAL is performed. Fever occurred significantly more frequently when BAL culture is positive. A single standard dose of the nonsteroidal anti‐inflammatory drug ibuprofen administered before a FOB does not prevent FPB.</description><identifier>ISSN: 8755-6863</identifier><identifier>EISSN: 1099-0496</identifier><identifier>DOI: 10.1002/ppul.24992</identifier><identifier>PMID: 32725954</identifier><language>eng</language><publisher>United States: Wiley Subscription Services, Inc</publisher><subject>Anti-Inflammatory Agents, Non-Steroidal - therapeutic use ; Bronchoalveolar Lavage - adverse effects ; Bronchoscopy ; Bronchoscopy - adverse effects ; Child ; Child, Preschool ; children ; Double-Blind Method ; Female ; fever ; Fever - drug therapy ; Humans ; ibuprofen ; Ibuprofen - therapeutic use ; Infant ; Lavage ; Male ; Nonsteroidal anti-inflammatory drugs ; Pediatrics ; Treatment Outcome</subject><ispartof>Pediatric pulmonology, 2020-10, Vol.55 (10), p.2737-2741</ispartof><rights>2020 Wiley Periodicals LLC</rights><rights>2020 Wiley Periodicals LLC.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c3572-f7833943adcc802fe732634f0d0d310fed4aebde6ccb7306dea00c7c3c0dbc8f3</citedby><cites>FETCH-LOGICAL-c3572-f7833943adcc802fe732634f0d0d310fed4aebde6ccb7306dea00c7c3c0dbc8f3</cites><orcidid>0000-0003-4037-0447 ; 0000-0001-6796-3459 ; 0000-0002-2891-642X ; 0000-0003-0235-0779</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/32725954$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Joseph, Leon</creatorcontrib><creatorcontrib>Goldberg, Shmuel</creatorcontrib><creatorcontrib>Cohen, Shlomo</creatorcontrib><creatorcontrib>Picard, Elie</creatorcontrib><title>Ibuprofen does not prevent postbronchoscopy fever in children undergoing broncho‐alveolar lavage</title><title>Pediatric pulmonology</title><addtitle>Pediatr Pulmonol</addtitle><description>Background
Fiber‐optic bronchoscopy (FOB) of the lower airways is a routine examination performed for investigating varying respiratory complaints in children. A common side effect is a transient high fever on the day of the FOB. Such episodes are usually unrelated to an infectious process but may cause clinical uncertainty and parental anxiety. We have previously shown that a single dose of systemic dexamethasone significantly reduces the rate of fever postbronchoscopy (FPB).
Research Question
To prospectively analyze the effect of a prophylactic dose of ibuprofen upon the FPB.
Study Design and Methods
Children presenting for elective FOB and broncho‐alveolar lavage (BAL) were randomized, in a double‐blind fashion, to receive a single dose of ibuprofen syrup 10 mg/kg or placebo prior to the procedure. Parents were contacted the next day to record the presence or absence of fever.
Results
Sixty‐one children were included in the final analysis. Thirty‐one children were in the treatment group and 30 in the placebo group. FPB occurred in 40 children (65%). There was no difference in the rate of FPB between placebo (63%) and treatment (67%) groups (P = .717). Fifty (82%) children had a positive BAL culture. Among them, 38 had FPB (76%) compared with only 2 of 11 (18%) of those with negative culture (P = .00026, relative risk 4.18). About 80% of positive cultures grew Haemophilus influenza. There was no significant difference between the number of BALs with a positive culture between the treatment and placebo groups (87% vs 77%, P = .35).
Conclusion
FPB occurs in around twothirds of children when BAL is performed. Fever occurred significantly more frequently when BAL culture is positive. A single standard dose of the nonsteroidal anti‐inflammatory drug ibuprofen administered before a FOB does not prevent FPB.</description><subject>Anti-Inflammatory Agents, Non-Steroidal - therapeutic use</subject><subject>Bronchoalveolar Lavage - adverse effects</subject><subject>Bronchoscopy</subject><subject>Bronchoscopy - adverse effects</subject><subject>Child</subject><subject>Child, Preschool</subject><subject>children</subject><subject>Double-Blind Method</subject><subject>Female</subject><subject>fever</subject><subject>Fever - drug therapy</subject><subject>Humans</subject><subject>ibuprofen</subject><subject>Ibuprofen - therapeutic use</subject><subject>Infant</subject><subject>Lavage</subject><subject>Male</subject><subject>Nonsteroidal anti-inflammatory drugs</subject><subject>Pediatrics</subject><subject>Treatment Outcome</subject><issn>8755-6863</issn><issn>1099-0496</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><recordid>eNp90MtOGzEUBmCratWE0A0PgEbqBiENHF_mtkSoLUiRYFHWI499nEzk2IOdCcquj8Az9klqSMqCBasj2Z9_-fyEnFC4oADschhGe8FE07BPZEqhaXIQTfmZTOuqKPKyLvmEHMW4Akh3Df1KJpxVrGgKMSXdbTcOwRt0mfYYM-c32RBwiy5NHzdd8E4tfVR-2GUmnYesd5la9laH9GZ0GsPC926RHeTfP8_SbtFbGTIrt3KBx-SLkTbit8OckYefP35f3-Tzu1-311fzXPGiYrmpas4bwaVWqgZmsOKs5MKABs0pGNRCYqexVKqrOJQaJYCqFFegO1UbPiNn-9y0z-OIcdOu-6jQWunQj7FlgtWCFnVJE_3-jq78GFz6XVIiVSMEQFLne6WCjzGgaYfQr2XYtRTal-bbl-bb1-YTPj1Ejt0a9Rv9X3UCdA-eeou7D6La-_uH-T70HwQ4kdc</recordid><startdate>202010</startdate><enddate>202010</enddate><creator>Joseph, Leon</creator><creator>Goldberg, Shmuel</creator><creator>Cohen, Shlomo</creator><creator>Picard, Elie</creator><general>Wiley Subscription Services, Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>K9.</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0003-4037-0447</orcidid><orcidid>https://orcid.org/0000-0001-6796-3459</orcidid><orcidid>https://orcid.org/0000-0002-2891-642X</orcidid><orcidid>https://orcid.org/0000-0003-0235-0779</orcidid></search><sort><creationdate>202010</creationdate><title>Ibuprofen does not prevent postbronchoscopy fever in children undergoing broncho‐alveolar lavage</title><author>Joseph, Leon ; Goldberg, Shmuel ; Cohen, Shlomo ; Picard, Elie</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3572-f7833943adcc802fe732634f0d0d310fed4aebde6ccb7306dea00c7c3c0dbc8f3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>Anti-Inflammatory Agents, Non-Steroidal - therapeutic use</topic><topic>Bronchoalveolar Lavage - adverse effects</topic><topic>Bronchoscopy</topic><topic>Bronchoscopy - adverse effects</topic><topic>Child</topic><topic>Child, Preschool</topic><topic>children</topic><topic>Double-Blind Method</topic><topic>Female</topic><topic>fever</topic><topic>Fever - drug therapy</topic><topic>Humans</topic><topic>ibuprofen</topic><topic>Ibuprofen - therapeutic use</topic><topic>Infant</topic><topic>Lavage</topic><topic>Male</topic><topic>Nonsteroidal anti-inflammatory drugs</topic><topic>Pediatrics</topic><topic>Treatment Outcome</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Joseph, Leon</creatorcontrib><creatorcontrib>Goldberg, Shmuel</creatorcontrib><creatorcontrib>Cohen, Shlomo</creatorcontrib><creatorcontrib>Picard, Elie</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>MEDLINE - Academic</collection><jtitle>Pediatric pulmonology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Joseph, Leon</au><au>Goldberg, Shmuel</au><au>Cohen, Shlomo</au><au>Picard, Elie</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Ibuprofen does not prevent postbronchoscopy fever in children undergoing broncho‐alveolar lavage</atitle><jtitle>Pediatric pulmonology</jtitle><addtitle>Pediatr Pulmonol</addtitle><date>2020-10</date><risdate>2020</risdate><volume>55</volume><issue>10</issue><spage>2737</spage><epage>2741</epage><pages>2737-2741</pages><issn>8755-6863</issn><eissn>1099-0496</eissn><abstract>Background
Fiber‐optic bronchoscopy (FOB) of the lower airways is a routine examination performed for investigating varying respiratory complaints in children. A common side effect is a transient high fever on the day of the FOB. Such episodes are usually unrelated to an infectious process but may cause clinical uncertainty and parental anxiety. We have previously shown that a single dose of systemic dexamethasone significantly reduces the rate of fever postbronchoscopy (FPB).
Research Question
To prospectively analyze the effect of a prophylactic dose of ibuprofen upon the FPB.
Study Design and Methods
Children presenting for elective FOB and broncho‐alveolar lavage (BAL) were randomized, in a double‐blind fashion, to receive a single dose of ibuprofen syrup 10 mg/kg or placebo prior to the procedure. Parents were contacted the next day to record the presence or absence of fever.
Results
Sixty‐one children were included in the final analysis. Thirty‐one children were in the treatment group and 30 in the placebo group. FPB occurred in 40 children (65%). There was no difference in the rate of FPB between placebo (63%) and treatment (67%) groups (P = .717). Fifty (82%) children had a positive BAL culture. Among them, 38 had FPB (76%) compared with only 2 of 11 (18%) of those with negative culture (P = .00026, relative risk 4.18). About 80% of positive cultures grew Haemophilus influenza. There was no significant difference between the number of BALs with a positive culture between the treatment and placebo groups (87% vs 77%, P = .35).
Conclusion
FPB occurs in around twothirds of children when BAL is performed. Fever occurred significantly more frequently when BAL culture is positive. A single standard dose of the nonsteroidal anti‐inflammatory drug ibuprofen administered before a FOB does not prevent FPB.</abstract><cop>United States</cop><pub>Wiley Subscription Services, Inc</pub><pmid>32725954</pmid><doi>10.1002/ppul.24992</doi><tpages>5</tpages><orcidid>https://orcid.org/0000-0003-4037-0447</orcidid><orcidid>https://orcid.org/0000-0001-6796-3459</orcidid><orcidid>https://orcid.org/0000-0002-2891-642X</orcidid><orcidid>https://orcid.org/0000-0003-0235-0779</orcidid></addata></record> |
fulltext | fulltext |
identifier | ISSN: 8755-6863 |
ispartof | Pediatric pulmonology, 2020-10, Vol.55 (10), p.2737-2741 |
issn | 8755-6863 1099-0496 |
language | eng |
recordid | cdi_proquest_miscellaneous_2428415861 |
source | Wiley |
subjects | Anti-Inflammatory Agents, Non-Steroidal - therapeutic use Bronchoalveolar Lavage - adverse effects Bronchoscopy Bronchoscopy - adverse effects Child Child, Preschool children Double-Blind Method Female fever Fever - drug therapy Humans ibuprofen Ibuprofen - therapeutic use Infant Lavage Male Nonsteroidal anti-inflammatory drugs Pediatrics Treatment Outcome |
title | Ibuprofen does not prevent postbronchoscopy fever in children undergoing broncho‐alveolar lavage |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-30T00%3A59%3A06IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Ibuprofen%20does%20not%20prevent%20postbronchoscopy%20fever%20in%20children%20undergoing%20broncho%E2%80%90alveolar%20lavage&rft.jtitle=Pediatric%20pulmonology&rft.au=Joseph,%20Leon&rft.date=2020-10&rft.volume=55&rft.issue=10&rft.spage=2737&rft.epage=2741&rft.pages=2737-2741&rft.issn=8755-6863&rft.eissn=1099-0496&rft_id=info:doi/10.1002/ppul.24992&rft_dat=%3Cproquest_cross%3E2442594400%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c3572-f7833943adcc802fe732634f0d0d310fed4aebde6ccb7306dea00c7c3c0dbc8f3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2442594400&rft_id=info:pmid/32725954&rfr_iscdi=true |